Login / Signup
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Jia Wei
Jianping Zhao
Meifang Han
Fankai Meng
Jianfeng Zhou
Published in:
Journal for immunotherapy of cancer (2020)
ChiCTR-OPN-1800018137.
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
immune response
chronic kidney disease
single cell
peritoneal dialysis
prognostic factors
stem cells
intensive care unit
bone marrow